Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 2
2006 1
2009 4
2010 1
2012 1
2014 1
2016 2
2017 6
2018 1
2019 3
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group. Gori S, et al. Among authors: trevisiol c. Crit Rev Oncol Hematol. 2019 Aug;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. Epub 2019 May 25. Crit Rev Oncol Hematol. 2019. PMID: 31176273 Free article.
State of the art and trends of circulating cancer biomarkers.
Gion M, Trevisiol C, Fabricio ASC. Gion M, et al. Among authors: trevisiol c. Int J Biol Markers. 2020 Feb;35(1_suppl):12-15. doi: 10.1177/1724600819900512. Int J Biol Markers. 2020. PMID: 32079467 Free article.
Insufficient uptake of systematic search methods in oncological clinical practice guideline: a systematic review.
Trevisiol C, Cinquini M, Fabricio ASC, Gion M, Rutjes AWS. Trevisiol C, et al. BMC Med Res Methodol. 2019 Aug 20;19(1):180. doi: 10.1186/s12874-019-0818-5. BMC Med Res Methodol. 2019. PMID: 31429714 Free PMC article.
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories.
Capoluongo E, La Verde N, Barberis M, Bella MA, Buttitta F, Carrera P, Colombo N, Cortesi L, Gion M, Guarneri V, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A, Gori S. Capoluongo E, et al. Among authors: trevisiol c. Diagnostics (Basel). 2019 Oct 9;9(4):146. doi: 10.3390/diagnostics9040146. Diagnostics (Basel). 2019. PMID: 31600986 Free PMC article.
Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice.
Ferraro S, Trevisiol C, Gion M, Panteghini M. Ferraro S, et al. Among authors: trevisiol c. Clin Chem. 2018 Feb;64(2):270-278. doi: 10.1373/clinchem.2017.275263. Epub 2017 Oct 11. Clin Chem. 2018. PMID: 29021329 Review.
Appropriateness of tumor marker request: a case of study.
Gion M, Trevisiol C, Fabricio ASC. Gion M, et al. Among authors: trevisiol c. Ann Transl Med. 2017 Jul;5(13):274. doi: 10.21037/atm.2017.06.19. Ann Transl Med. 2017. PMID: 28758100 Free PMC article.
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation.
Trevisiol C, Gion M, Vaona A, Fabricio ASC, Roca E, Licitra L, Alfieri S, Bossi P. Trevisiol C, et al. Oral Oncol. 2021 Jan 11;114:105128. doi: 10.1016/j.oraloncology.2020.105128. Online ahead of print. Oral Oncol. 2021. PMID: 33444925 Review.
Indicators of inappropriate tumour marker use through the mining of electronic health records.
Gion M, Cardinali G, Trevisiol C, Zappa M, Rainato G, Fabricio ASC. Gion M, et al. Among authors: trevisiol c. J Eval Clin Pract. 2017 Aug;23(4):895-902. doi: 10.1111/jep.12754. Epub 2017 May 15. J Eval Clin Pract. 2017. PMID: 28503788
Epidemiology-based assessment of tumor marker overordering in breast cancer: an algorithm to examine different disease conditions.
Trevisiol C, Gion M, Dittadi R, Zappa M, Fabricio ASC. Trevisiol C, et al. Int J Biol Markers. 2017 Oct 31;32(4):e471-e473. doi: 10.5301/ijbm.5000274. Int J Biol Markers. 2017. PMID: 28561878 Free article.
Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2).
Gion M, Trevisiol C, Rutjes AWS, Rainato G, Fabricio ASC. Gion M, et al. Among authors: trevisiol c. Int J Biol Markers. 2017 Mar 2;32(1):e1-e52. doi: 10.5301/ijbm.5000259. Int J Biol Markers. 2017. PMID: 28255982 Free article. No abstract available.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback